Understanding resistance to targeted therapies in head and neck, breast cancer

MSN highlights University of Cincinnati Cancer Center research

MSN highlighted University of Cincinnati Cancer Center and Cincinnati Veterans Affairs Medical Center research published in the journal Oncotarget that reviewed current research on why Epidermal Growth Factor Receptor (EGFR)-targeted therapies often fail in breast and head and neck cancers. 

The review, led by co-corresponding authors Vinita Takiar, MD, and Susan Waltz, PhD, offers an in-depth look at the molecular barriers to EGFR inhibition and provides insights that could inform the development of more effective and durable treatments.

EGFR is a critical protein that regulates cell growth and survival, and it is frequently overexpressed in breast and head and neck cancers. Although therapies targeting EGFR showed early promise, resistance has become a significant challenge.

The review analyzes resistance mechanisms in breast cancer including the movement of EGFR from the cell surface into the nucleus, promoting DNA repair. By analyzing these resistance mechanisms, the authors highlight combination therapies from current research that target EGFR and other key molecular pathways that may enhance treatment outcomes.

"A recent phase 1 study has shown that patients with recurrent or metastatic head and neck cancer who received BCA101, a bifunctional dual targeting drug that targets EGFR and TGF-β in combination with pembrolizumab, were able to achieve an overall response rate of 65%," the coauthors noted.

Read the MSN article.

Featured photo at top of pink Breast Cancer Awareness ribbon. Photo/Lludmila Chernetska/iStock.

Related Stories

1

When grief doesn't end: Nursing PhD students bring a classroom theory to Ohio families

October 29, 2026

Most of us think of grief as something with an ending. A loss happens, it hurts, and over time the hurt fades. For many parents of children with developmental disabilities, it doesn't work that way. The sadness can quiet down for months or years and then come back. It might return on the first day of kindergarten, at a cousin's wedding, at a high school graduation, or on the day a young adult ages out of school services. Nurses and researchers have a name for this: chronic sorrow. Last October, two University of Cincinnati College of Nursing PhD students helped bring that name to a room of families, people with disabilities and the professionals who support them.